MedPath

Roche Holding AG

Roche Holding AG logo
๐Ÿ‡จ๐Ÿ‡ญSwitzerland
Ownership
Public
Established
1896-01-15
Employees
103.6K
Market Cap
$270.5B
Website
http://www.roche.com

A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Non-Hodgkin's Lymphoma
Interventions
First Posted Date
2011-07-07
Last Posted Date
2016-11-02
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
40
Registration Number
NCT01388959

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs

Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2011-07-06
Last Posted Date
2016-11-02
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
64
Registration Number
NCT01388309

An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)

Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2011-06-29
Last Posted Date
2016-11-02
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
251
Registration Number
NCT01384461

A Study of RO5458640 in Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
Neoplasms
Interventions
Drug: RO5458640
First Posted Date
2011-06-28
Last Posted Date
2016-11-02
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
54
Registration Number
NCT01383733

A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
Interventions
First Posted Date
2011-06-28
Last Posted Date
2017-06-14
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
77
Registration Number
NCT01383707
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Irccs Ospedale San Raffaele;Oncologia Medica, Milano, Lombardia, Italy

๐Ÿ‡ฎ๐Ÿ‡น

Centro Catanese Di Oncologia; Oncologia Medica, Catania, Sicilia, Italy

๐Ÿ‡ฎ๐Ÿ‡น

IRCCS Istituto Nazionale Tumori Fondazione Pascale; Oncologia Medica A, Napoli, Campania, Italy

and more 8 locations

A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis

Phase 4
Completed
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2011-06-27
Last Posted Date
2017-08-01
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
351
Registration Number
NCT01382940
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clnical & Translational Reseach Center for Alabama, PC, Tuscaloosa, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

ArthroCare, Arthritis Care; and Research P.C., Gilbert, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Catalina Pointe Rheumatology, Tucson, Arizona, United States

and more 81 locations

A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)

Completed
Conditions
Anemia, Kidney Disease, Chronic
First Posted Date
2011-06-23
Last Posted Date
2017-07-13
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
780
Registration Number
NCT01379963
Locations
๐Ÿ‡ฌ๐Ÿ‡ท

Pantokrator Private Clinic; Nephrology, Athens, Greece

๐Ÿ‡ฌ๐Ÿ‡ท

General Hospital of Artas; Nephrology, Arta, Greece

๐Ÿ‡ฌ๐Ÿ‡ท

Kyanos Stavros Private Hospital; Nephrologic Clinic, Athens, Greece

and more 14 locations

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)

Phase 2
Completed
Conditions
Non-Squamous Non-Small Cell Lung Cancer
Interventions
First Posted Date
2011-06-23
Last Posted Date
2018-01-23
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
50
Registration Number
NCT01378962
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia, Rozzano, Lombardia, Italy

๐Ÿ‡ฎ๐Ÿ‡น

Istituto Regina Elena; Oncologia Medica A, Roma, Lazio, Italy

๐Ÿ‡ฎ๐Ÿ‡น

A.O. Universitaria Policlinico Di Modena; Ematologia, Modena, Emilia-Romagna, Italy

and more 7 locations

A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

Phase 2
Completed
Conditions
Malignant Melanoma
Interventions
First Posted Date
2011-06-23
Last Posted Date
2016-08-01
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
146
Registration Number
NCT01378975

A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients

Phase 4
Completed
Conditions
Kidney Transplantation, Cytomegalovirus Infections
Interventions
First Posted Date
2011-06-20
Last Posted Date
2017-07-11
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
57
Registration Number
NCT01376804
Locations
๐Ÿ‡ฒ๐Ÿ‡ฝ

Instituto Mexicano de Transplantes, Cuernavaca, Mexico

๐Ÿ‡ฆ๐Ÿ‡บ

Royal Children'S Hospital; Department of Nephrology, Parkville, Victoria, Australia

๐Ÿ‡บ๐Ÿ‡ธ

UCLA Center For Health Sciences; Division of Pediatric Nephrology, Los angeles, Louisiana, United States

and more 22 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath